Oxford- AstraZeneca announced the results of observatory data from phase I/II of their vaccine trial on July 20.
The results have raised expectations that getting a vaccine before 2021
. the crisis at large, AstraZeneca, the pharma company has already inked
deals with several vaccine manufacturers globally to production of the novel vaccine.
|Coronavirus Vaccine News|
Oxford-AstraZeneca's trial study:
According to the study which has been published
How do viral vectors work?
Provide immunity against COVID-19?volunteers administered a dosage of the injection saw a spike up
Vaccine may push herd immunity fasterEarly observations have also
It was also seen that the strongest immunization was achieved
Work for everyone?
Phase I/II trials were done on a smaller batch of volunteers,
Phase III of the trial